Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development by Zaloumis Sophie, Humberstone Andrew, Charman Susan A, Price Ric N, Moehrle Joerg, Gamo-Benito Javier, McCaw James, Jamsen Kris M, Smith Katherine, Simpson Julie A

Get full text

Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice by Shackleford David M, Roncal Norma, Norval Suzanne, Read Kevin D, Moon Jay, McCalmont William, Mannila Anne, Lanteri Charlotte, Kozar Michael, Gerena Lucia, Gardner Sean, Caridha Diana, Bhonsle Jayendra, Bathurst Ian, Milner Erin, Dow Geoffrey S, Sousa Jason, Steuten Jessica, White Karen L, Zeng Qiang, Charman Susan A

Get full text

Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase Inhibitors by Okaniwa, Masanori, Shibata, Akira, Ochida, Atsuko, Akao, Yuichiro, White, Karen L, Shackleford, David M, Duffy, Sandra, Lucantoni, Leonardo, Dey, Sumanta, Striepen, Josefine, Yeo, Tomas, Mok, Sachel, Aguiar, Anna Caroline C, Sturm, Angelika, Crespo, Benigno, Sanz, Laura M, Churchyard, Alisje, Baum, Jake, Pereira, Dhelio B, Guido, Rafael VC, Dechering, Koen J, Wittlin, Sergio, Uhlemann, Anne-Catrin, Fidock, David A, Niles, Jacquin C, Avery, Vicky M, Charman, Susan A, Laleu, Benoît

Get full text